Quark Biosciences

QuarkBio aims to enable precision medicine through our NextAmp™ Analysis System by delivering biomarker panels to resolve unmet clinical needs.

[Quark Biosciences @quarkbio]

Visit us at Healthcare Expo Taiwan 2022 to explore the many possibilities of our NextAmp™ Analysis System!
📌Booth no.: L003
📌Location: Taipei Nangang Exhibition Center, Hall 1, 4F
📌Date: 2022/12/01 (Thu) - 04 (Sun)
📌 Time: 10:00 am - 06:00 pm (Last day until 4:00 pm)

[Quark Biosciences @quarkbio]

Join us at MEDICA 2022 to see our innovative oncology diagnostic platform!

Register now https://t.co/uE7Ju29Uvv

Booth no.: Hall17 Stand C22-I
Date: 14 - 17 November, 2022

#QuarkBio #MEDICA2022 #NextAmp #PrecisionMedicine

[Quark Biosciences @quarkbio]

QuarkBio wishes everyone a Happy Moon Festival!

#QuarkBio #MoonFestival

[Quark Biosciences @quarkbio]

Visit us at BIO Asia-Taiwan 2022 to explore the many possibilities of our NextAmp™ Analysis System!
📌Booth no.: R121
📌Location: Taipei Nangang Exhibition Center, Hall 2, 4F
📌Date: 2022/7/28(Thu)-31(Sun)
📌Time: 10:00am-06:00pm (Last day until 5pm)
#Quarkbio #BioAsia #NextAmp

[Quark Biosciences @quarkbio]

2022年2月24日(木)～26日(土)「第8回 医療と介護の総合展」に出展いたします。
Booth no.: Hall 4 Stand 1-36J
招待券を来場する：https://t.co/TCdSAjRvUa
皆様のご来場を心よりお待ち申し上げております。
See you at Medical Japan 2022 Osaka!

#quarkbio #医療と介護の総合展 #メディカ��ジャパン

[Quark Biosciences @quarkbio]

Our first original article https://t.co/LxLkxeqewB was selected for review in the prestigious journal #FertilityandSterility, highlighting the innovative and promising uses of miRNA biomarkers to overcome repeated implantation failure. https://t.co/UeIYIC3G2b

[Quark Biosciences @quarkbio]

In the recent interview with @PharmaBoardroom, our Chairman and CBO outline QuarkBio's alternative platform for molecular diagnostics, and how it is used in the areas of oncology and reproductive medicine. Check out here https://t.co/DVtgm6h1gN
#Quarkbio #NGS #precisionmedicine

[Quark Biosciences @quarkbio]

Large scale studies have shown that 30% of infertility patients have a displaced window of implantation (WOI).
MIRA™ is able to assess endometrial receptivity to determine the optimal time for embryo transfer with a successful implantation rate of over 70%.#IVF #infertility

[Quark Biosciences @quarkbio]

👏We are proud to announce our latest research achievement using NextAmp Analysis System to build an algorithm capable of successfully predicting repeated implantation failure patients with over 90% accuracy was recently published by #FertStert.
📜https://t.co/TchyPNq5dG
#MIRA

[Quark Biosciences @quarkbio]

MIRA's development team at QuarkBio wishes you a Happy Mother's Day.

#MIRAbabies #QuarkBio #HappyMothersDay

[Quark Biosciences @quarkbio]

Exciting News! We won the iF DESIGN AWARD 2021 with NextAmp™ Analysis System in the Product discipline.

Contact us for more details: https://t.co/lZG10bm7wq

#ifdesignaward2021 #ifdesign #Nextamp #quarkbio #gixia

[Quark Biosciences @quarkbio]

Our pioneering product MIRA™, a miRNA-based endometrial receptivity analysis, is proud to join Mediaplanet’s Future of Fertility campaign in USA Today.

Learn more about MIRA™ and contact us at https://t.co/mMPJmvqdmi

#MIRA #quarkbio #USAtoday #IVF #infertility #fertility

[Quark Biosciences @quarkbio]

QuarkBio has received the CE IVD mark for our Q Station™ Dx 1000, for use as an in vitro diagnostic (IVD) device in the European Union. With the CE IVD mark, we are poised for the European market and eventually other global regions.
#quarkbio #ceivd

https://t.co/vkO0A5JUVc

[Quark Biosciences @quarkbio]

QuarkBio’s pioneering product - MIRA™ endometrial receptivity analysis has successfully helped a mother overcome 9 miscarriages
#MIRA

For more information: https://t.co/R40afnF88l

[Quark Biosciences @quarkbio]

We’re excited to announce that our NextAmp™ Analysis System has made the final round of the iF DESIGN AWARD 2021! Since 1954, the prestigious award has identified outstanding design and quality as it relates to business & everyday life.https://t.co/612rW8jVtT #ifdesignaward2021

[Quark Biosciences @quarkbio]

QuarkBio visited Taoyuan with LiChangRong Group and the Wego Cultural and Education Foundation on Tue (2/2) to donate 2 ultra-sensitive diagnostic devices and 1000 sets of DigiChip™ SARS-CoV-2 Assays to the fontline medical staff. https://t.co/ulP36heOET

[Quark Biosciences @quarkbio]

Happy Holidays from Quark Biosciences!

It has been a tough year for everyone, and we wish that the coming year brings more new possibilities.

We wish you and your family a safe and happy Holiday!
#QuarkBio

[Quark Biosciences @quarkbio]

We were invited to present at the Advancing Molecular Diagnostics in Precision Medicine Symposium on Nov. 1st, 2020, hosted by Chung Shan Medical University.
Special thanks to Dr. Jen-Fan Hang & Dr. Hung-Chih Lai for sharing their experience using our NextAmp™ Analysis System!

[Quark Biosciences @quarkbio]

Thank you for everyone’s support and attendance at the 2020 First Endometrial Receptivity Research Progress Symposium!
We look forward to providing additional platforms for experts in the reproductive medicine field to get together and share their experiences in the near future!!

[Quark Biosciences @quarkbio]

2020 First Seminar on Research Progress in Endometrial Receptivity

Symposium Information
Time: 13:30-17:00, October 25, 2020 (Sunday)
Organizer: Hangzhou Neolin Technology Co., Ltd.

Visit Neoline for further information:
https://t.co/0erRnQXx24